Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-03

Clinical Trial Update: Ginkgo Biloba and Ocular Blood Flow in Primary Open-angle Glaucoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update assessing Ginkgo Biloba for improving ocular blood flow in primary open-angle glaucoma; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ginkgo biloba (Ginkgo biloba)

Snippet

Sponsor: Maisonneuve-Rosemont Hospital | Conditions: Glaucoma, Open-Angle | Phase 2 | Status: COMPLETED